Results 131 to 140 of about 3,449 (222)

Can we “terminate” alloimmune platelet transfusion refractoriness? [PDF]

Transfusion, 2016
Ralph R, Vassallo, Philip J, Norris
openaire   +2 more sources

[Incidence and clinical significance of platelet transfusion refractoriness after allogeneic hematopoietic stem cell transplantation in patients with chronic myelomonocytic leukemia]. [PDF]

Zhonghua Xue Ye Xue Za Zhi, 2022
Zhao C, Zhao XS, Wang Y, Yan CH, Xu LP, Zhang XH, Liu KY, Huang XJ, Sun YQ.   +8 more
europepmc   +1 more source

Platelet transfusion refractoriness: how do I diagnose and manage? [PDF]

Hematology Am Soc Hematol Educ Program, 2020
Cohn CS.
europepmc   +1 more source

Immune platelet transfusion refractoriness in pediatric patients undergoing HSCT

Egyptian Pediatric Association Gazette
Background Children who undergo hematopoietic stem cell transplantation (HSCT) sometimes have immune platelet transfusion refractoriness (IPTR). The thrombopoietin receptor agonist (TPO-RA) is used to increase platelet counts in a variety of immune ...
Olivera Serbic, Zorana Andric, Svetlana Vojvodic, Dragomir Djokic, Marija Simic   +4 more
doaj   +1 more source

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients [PDF]

, 2017
Haas, M. (Masja) de, Holt, B. (Bronno) van der, Huiskes, E. (Elly), Porcelijn, L., Schipperus, M.R. (Martin), Zwaginga, J.J. (Jaap)   +5 more
core   +1 more source

Genetic Influences on Platelet Function in Coronary Artery Disease and Myocardial Infarction.

, 2008
Imperial Users ...
HomeyraDouglas, HomeyraDouglas
core  

Supply chain management of blood products: a literature review. [PDF]

This paper presents a review of the literature on inventory and supply chain management of blood products. First, we identify different perspectives on approaches to classifying the existing material. Each perspective is presented as a table in which the
Belien, Jeroen, Forcé, Hein
core  

A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients. [PDF]

Br J Haematol, 2020
Vo P, Purev E, West KA, McDuffee E, Worthy T, Cook L, Hawks G, Wells B, Shalabi R, Flegel WA, Adams SD, Reger R, Aue G, Tian X, Childs R.   +14 more
europepmc   +1 more source

Platelet desialylation, apoptosis, and T-lymphocyte-mediated immune dysregulation: unveiling the pathways of platelet clearance in platelet transfusion refractoriness. [PDF]

Res Pract Thromb Haemost
Zhou Y, Zhong Z, Mo H, Liang L, Su C, Chen Y, Lu F, Huang Y, Wu G.   +8 more
europepmc   +1 more source

Marked platelet transfusion refractoriness caused by anti-HLA-I and anti-HPA-5b antibodies: A case report. [PDF]

Medicine (Baltimore)
Wang Y, Liu Z, Duan S, Lin C, Jin Y, Wang H, Wang Y, Tang L, Wang M.   +8 more
europepmc   +1 more source